State Street Corp Procaps Group, S.A. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.51 - $2.97 $50 - $59	20 Added 0.16%	12,383 $31,000
Q1 2024 May 15, 2024	BUY	$2.78 - $4.7 $347 - $587	125 Added 1.02%	12,363 $35,000
Q4 2023 Feb 14, 2024	BUY	$2.18 - $4.14 $1,874 - $3,560	860 Added 7.56%	12,238 $49,000
Q3 2023 Nov 14, 2023	SELL	$3.5 - $4.31 $12,425 - $15,300	-3,550 Reduced 23.78%	11,378 $41,000
Q2 2023 Aug 14, 2023	BUY	$3.84 - $5.04 $1,555 - $2,041	405 Added 2.79%	14,928 $64,000
Q1 2023 May 15, 2023	BUY	$3.68 - $5.27 $3,367 - $4,822	915 Added 6.72%	14,523 $65,000
Q4 2022 Feb 14, 2023	BUY	$4.89 - $7.37 $4,669 - $7,038	955 Added 7.55%	13,608 $71,000
Q3 2022 Nov 15, 2022	BUY	$0.8 - $8.85 $10,122 - $111,979	12,653 New	12,653 $89,000

53.3K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $104M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.